- KR₩1tn
- KR₩881bn
- KR₩474bn
Brief: Seegene reports H1 2022 results
Brief: Seegene To Pave Way For Pcr Testing At Local Clinics With EU-Approved Multiplex Test And Fully Automated Pcr Solution
Brief: Seegene Develops Pcr Test To Detect Monkeypox Virus
Brief: Seegene Reports First Quarter 2022 Financial Results
Brief: Seegene Appoints Richard Creager As CEO Of U.S. Subsidiary
Brief: Seegene Announces Q4 And Full-Year 2021 Financial Results
Brief: Seegene Signs Supply Deal To Deliver 4 Million Covid-19 Tests To Brazil
Brief: Seegene To Launch New COVID-19 PCR Test
Brief: Seegene's Allplex™ SARS CoV-2 FluA/FluB/RSV Assay Approved Under Health Canada's Interim Order
Brief: Seegene Continues To Support Israel's Effort To Manage The Omicron Variant With Timely Delivery Of Five Million Tests
Brief: Seegene Inc - Will Deliver 1.7 mln COVID-19 Testing Reagents By A Private Plane To Israel
Brief: Seegene's High Multiplex PCR Assay Capable Of Detecting New Omicron Variant
Brief: Seegene Introduces New SARS-CoV-2 Variants Detection Test
Brief: Seegene Announces Partnership With Bio-Rad To Develop Diagnostic Testing Products For The U.S. Market
Brief: Microbix & Seegene Canada Form Covid-Variant Collaboration
Brief: Seegene Announces Submission To U.S. FDA For Emergency Use Authorization Of Its Allplextm Sars-Cov-2/Flua/Flub/Rsv Assay
S.Korea's Seegene develops first COVID-19 test kit that can detect multiple variants
S.Korea's COVID-19 test kit makers, vaccine makers fall after Pfizer vaccine report
Brief: Seegene Introduces A High-Throughput 8-Plex Test For Flu A, Flu B, Rsv And Covid-19 With Dual Internal Controls